MetaCap

Greenland Mines (GRML) vs Instil Bio (TIL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Instil Bio (TIL) has outperformed Greenland Mines (GRML) over the past year, losing 60.2% versus a loss of 87.1%. Greenland Mines is the larger company by market cap ($44.3 million vs $35.5 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GRML-87.08%TIL-60.20%
+46%-24%-94%
Nov 21, 20251 yearNov 20, 2026
GRML-99.40%TIL-96.30%
+32%-37%-106%
Apr 25, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GRML versus TIL key metrics
MetricGRMLTIL
Share price$2.99$5.23
Market cap$44.31M$35.47M
1-day change+2.75%-5.77%
YTD return-79.31%-52.45%
1-year return-87.08%-60.20%
5-year return—-98.72%
EPS (TTM)$-9.74$-3.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$10.77M
Revenue growth (YoY)—+152.38%
Net income (latest FY)$-10.55M$-71.37M
Operating margin—-745.39%
Net margin—-662.75%
52-week high$37.00$12.92
52-week low$2.75$5.14
Distance from 52-week high-91.92%-59.51%
Analyst consensusnonenone
Avg. price target upside+3578.93%+33.84%
Average volume8.93M42.02K
Shares outstanding14.82M6.78M
Employees517
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TIL has outperformed GRML by 26.9 percentage points over the past year.

About Greenland Mines

GRML stock →

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 5 employees

About Instil Bio

TIL stock →

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 17 employees

GRML vs TIL FAQ

Which is bigger, Greenland Mines or Instil Bio?

Greenland Mines (GRML) is larger, with a market capitalization of $44.31M compared with $35.47M for Instil Bio (TIL).

Which stock has performed better over the past year, GRML or TIL?

TIL returned -60.20% over the past 12 months, compared with -87.08% for GRML (price return, excluding dividends). Past performance does not predict future results.

Are Greenland Mines and Instil Bio in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons